as on October 31, 2025 at 1:29 am IST
Day's Low
Day's High
0.50%
Downside
14.86%
Upside
52 Week's Low
52 Week's High
62.97%
Downside
290.18%
Upside
Check Artiva Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$115.5M
EPS (TTM)
-3.13
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-86.18%
Compare market cap, revenue, PE, and other key metrics of Artiva Biotherapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $115.5M | NA | NA | 0.00% | |
| BUY | $62.4B | 291.63% | -505.15 | -12.96% | |
| NA | $36.4B | NA | NA | -3.89% | |
| BUY | $108.3B | 100.24% | 30.02 | 31.86% | |
| BUY | $69.4B | 20.12% | 15.7 | 32.13% |
The Artiva Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Artiva Biotherapeutics Inc investment value today
Current value as on today
₹44,780
Returns
Returns from Artiva Biotherapeutics Inc Stock
Dollar Returns*
₹5,667 (+5.67%)
Investment in Artiva Biotherapeutics Inc Shares on INDmoney has grown by 9600.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:9600.00% versus previous 30 day period
Search interest for Artiva Biotherapeutics Inc Stock has increased by 1575% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1575% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.1% return, outperforming this stock by 127.8%
Price Dip
![]()
In the last 7 days, ARTV stock has moved down by -9.3%
| Organisation | Artiva Biotherapeutics Inc |
| Headquarters | 5505 Morehouse Drive, San Diego, CA, United States, 92121 |
| CEO | Dr. Fred Aslan M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Neha Krishnamohan | CFO & Executive VP of Corporate Development |
Dr. Heather Raymon Ph.D. | Senior Vice President of Research & Early Development |
Dr. Subhashis Banerjee M.D. | Chief Medical Officer |
Mr. Christopher P. Horan | Chief Technical Operations Officer |
Dr. David Moriarty Ph.D. | Senior VP of Clinical Operations |
Mr. Benjamin Dewees | Senior Vice President of Regulatory Affairs |
Mr. Feng Xu | Senior Vice President of Biometrics |
Dr. Fred Aslan M.D. | President, CEO & Director |
Ms. Jennifer Kinsbruner Bush Esq., J.D. | Executive VP, COO, Chief Legal Officer, Corporate Secretary & Compliance Officer |
Dr. Peter Flynn Ph.D. | Co-Founder & Strategic Advisor |
Artiva Biotherapeutics Inc share price today is $3.97 as on at the close of the market. Artiva Biotherapeutics Inc share today touched a day high of $4.56 and a low of $3.95.
Artiva Biotherapeutics Inc share touched a 52 week high of $15.49 on and a 52 week low of $1.47 on . Artiva Biotherapeutics Inc stock price today i.e. is closed at $3.97,which is 74.37% down from its 52 week high and 170.07% up from its 52 week low.
Artiva Biotherapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Artiva Biotherapeutics Inc (ARTV) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Artiva Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Artiva Biotherapeutics Inc share’s latest price of $3.97 as on October 31, 2025 at 1:29 am IST, you will get 2.5189 shares of Artiva Biotherapeutics Inc. Learn more about
fractional shares .